These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31476946)

  • 1. Cytokines in peritoneal fluid of ovarian neoplasms.
    de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
    J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascitic interleukin-12 is an independent prognostic factor in ovarian cancer.
    Zeimet AG; Widschwendter M; Knabbe C; Fuchs D; Herold M; Müller-Holzner E; Daxenbichler G; Offner FA; Dapunt O; Marth C
    J Clin Oncol; 1998 May; 16(5):1861-8. PubMed ID: 9586902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms.
    Micheli DC; Jammal MP; Martins-Filho A; Côrtes JRXM; Souza CN; Nomelini RS; Murta EFC; Tavares-Murta BM
    Biomarkers; 2020 Sep; 25(6):474-482. PubMed ID: 32544350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer.
    Rodrigues ISS; Martins-Filho A; Micheli DC; Lima CA; Tavares-Murta BM; Murta EFC; Nomelini RS
    Immunol Invest; 2020 Jul; 49(5):510-521. PubMed ID: 31755326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between interleukin-10 level in ascites of patients with primary ovarian epithelial carcinoma and immune defect in peritoneal cavity].
    Zhou JW; Cheng Q; Xie X; Chen HZ; Ye DF; Lu WG
    Ai Zheng; 2004 May; 23(5):573-6. PubMed ID: 15142457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas.
    Crispim PCA; Jammal MP; Antão PKA; Micheli DC; Tavares-Murta BM; Murta EFC; Nomelini RS
    Am J Reprod Immunol; 2020 Dec; 84(6):e13309. PubMed ID: 32698242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual/recurrent disease examination.
    Chechlinska M; Kaminska J; Markowska J; Kramar A; Steffen J
    Int J Biol Markers; 2007; 22(3):172-80. PubMed ID: 17922459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
    Daraï E; Detchev R; Hugol D; Quang NT
    Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased IL-1 RA concentration in ascites is associated with a significant improvement in overall survival in ovarian cancer.
    Mustea A; Pirvulescu C; Könsgen D; Braicu EI; Yuan S; Sun P; Lichtenegger W; Sehouli J
    Cytokine; 2008 Apr; 42(1):77-84. PubMed ID: 18329282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies.
    Sipak-Szmigiel O; Włodarski P; Ronin-Walknowska E; Niedzielski A; Karakiewicz B; Słuczanowska-Głąbowska S; Laszczyńska M; Malinowski W
    J Ovarian Res; 2017 Apr; 10(1):25. PubMed ID: 28376925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.
    Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R
    J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers.
    Gotlieb WH; Abrams JS; Watson JM; Velu TJ; Berek JS; Martínez-Maza O
    Cytokine; 1992 Sep; 4(5):385-90. PubMed ID: 1421000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
    Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
    J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
    Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
    Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancer.
    Yigit R; Figdor CG; Zusterzeel PL; Pots JM; Torensma R; Massuger LF
    Eur J Cancer; 2011 Aug; 47(12):1883-9. PubMed ID: 21514148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian carcinoma cells and IL-1beta-activated human peritoneal mesothelial cells are possible sources of vascular endothelial growth factor in inflammatory and malignant peritoneal effusions.
    Stadlmann S; Amberger A; Pollheimer J; Gastl G; Offner FA; Margreiter R; Zeimet AG
    Gynecol Oncol; 2005 Jun; 97(3):784-9. PubMed ID: 15943987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiling of ascites at primary surgery identifies an interaction of tumor necrosis factor-α and interleukin-6 in predicting reduced progression-free survival in epithelial ovarian cancer.
    Kolomeyevskaya N; Eng KH; Khan AN; Grzankowski KS; Singel KL; Moysich K; Segal BH
    Gynecol Oncol; 2015 Aug; 138(2):352-7. PubMed ID: 26001328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis.
    Eriksson AS; Gretzer C; Wallerstedt S
    Hepatogastroenterology; 2004; 51(56):505-9. PubMed ID: 15086192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors.
    Punnonen R; Teisala K; Kuoppala T; Bennett B; Punnonen J
    Cancer; 1998 Aug; 83(4):788-96. PubMed ID: 9708947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.